Thursday, June 11, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 135 of 200 Β· By data quality, then INN

  1. recombinant human c1 inhibitor

    RHUCIN

    EMA: refused

    B06C
  2. recombinant respiratory syncytial virus pre-fusion f protein, adjuvanted with as01e

    AREXVY

    EMA: approved

    J07BX05
  3. recombinant salmon calcitonin

    FORCALTONIN

    EMA: withdrawn

    H05BA01
  4. regdanvimab

    REGKIRONA

    EMA: withdrawn

    J06BD06
  5. relatlimab

    OPDUALAG

    EMA: approved

    L01FY02
  6. remimazolam

    BYFAVO

    EMA: approved Β· NMPA: clinical trials

    N05CD14
  7. resminostat

    KINSELBY

    EMA: unknown

    L01X
  8. respiratory syncytial virus vaccine (bivalent, recombinant)

    ABRYSVO

    EMA: approved

    J07BX05
  9. reteplase

    ECOKINASE

    FDA: approved Β· EMA: withdrawn

    B01AD07
  10. retifanlimab

    ZYNYZ

    EMA: approved

    L01FF10
  11. retigabine

    TROBALT

    EMA: withdrawn

    N03AX21
  12. rezafungin

    REZZAYO

    EMA: approved

    J02AX08
  13. rimonabant

    ZIMULTI

    EMA: withdrawn

    A08AX01
  14. risankizumab

    SKYRIZI AbbVie

    EMA: approved Β· TGA: approved Β· PMDA: approved

    L04AC18
  15. ritlecitinib

    LITFULO

    EMA: approved

    L04AF08
  16. rolapitant

    VARUBY

    EMA: withdrawn

    A04AD
  17. romosozumab

    EVENITY Amgen

    EMA: approved Β· TGA: approved Β· PMDA: approved

    M05BX
  18. ropeginterferon alfa-2b

    BESREMI

    EMA: approved

    L03AB15
  19. rosiglitazone

    AVANDAMET

    EMA: unknown

    A10BD03
  20. rotavirus vaccine

    ROTASHIELD

    EMA: withdrawn

    J07BH
  21. rotavirus vaccine, live

    ROTARIX

    EMA: approved

    J07BH01
  22. roxadustat

    EVRENZO

    EMA: approved Β· PMDA: approved Β· NMPA: clinical trials

    B03XA05
  23. rozanolixizumab

    RYSTIGGO

    EMA: approved

    L04AL02
  24. rubitecan

    ORATHECIN

    EMA: application withdrawn

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.